Cargando…
Galantamine improves glycemic control and diabetic nephropathy in Lepr(db/db) mice
Galantamine, a centrally acting acetylcholinesterase inhibitor, has been shown to attenuate inflammation and insulin resistance in patients with metabolic syndrome. We investigated the effects of galantamine on glycemic control and development of diabetic nephropathy (DN) in Lepr(db/db) mice. Galant...
Autores principales: | Meng, Qinghe, Ma, Julia, Suo, Liye, Pruekprasert, Napat, Chakrapani, Prithi, Cooney, Robert N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511534/ https://www.ncbi.nlm.nih.gov/pubmed/37731032 http://dx.doi.org/10.1038/s41598-023-42665-2 |
Ejemplares similares
-
GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Lepr(db/db) mice
por: Meng, Qinghe, et al.
Publicado: (2022) -
Overexpression of lipoic acid synthase gene alleviates diabetic nephropathy of Lepr(db/db) mice
por: Zhao, Yingzheng, et al.
Publicado: (2021) -
Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Lepr(db)/+Lepr(db) Mice
por: Ohno, Tomohiko, et al.
Publicado: (2015) -
Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
por: Seo, Jung-Woo, et al.
Publicado: (2015) -
Lepr(db/db) Mice with Senescence Marker Protein-30 Knockout (Lepr(db/db)Smp30(Y/−)) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet
por: Kondo, Yoshitaka, et al.
Publicado: (2013)